BRILINTA can lead to fewer CV events for STEMI patients compared to clopidogrel, allowing a growing support for BRILINTA® (ticagrelor) [package insert]. Find out about the BRILINTA® (ticagrelor) mechanism of action. BRILINTA is the first-and-only ;(3) BRILINTA® (ticagrelor) [package insert]. Patient Information Leaflet. Package leaflet: Information for the user. Brilique 90 mg film-coated tablets ticagrelor. Read all of this leaflet carefully before you start .

Author: Grot Fenrijar
Country: Austria
Language: English (Spanish)
Genre: Technology
Published (Last): 18 May 2012
Pages: 243
PDF File Size: 4.2 Mb
ePub File Size: 14.83 Mb
ISBN: 553-2-63660-641-8
Downloads: 20817
Price: Free* [*Free Regsitration Required]
Uploader: Votilar

Plavix is a registered trademark of sanofi-aventis. Plavix should be administered in conjunction with aspirin. Strong inhibitors substantially increase ticagrelor exposure and so increase the risk of adverse events. Tell your doctor if you take brilihta medicines that contain aspirin.


For at least the first 12 months following ACS, it is superior to clopidogrel. Plavix is indicated to reduce the rate of myocardial infarction and stroke Indert in patients with acute ST-elevation myocardial infarction STEMI who are to be managed medically.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. The optimal duration of Plavix therapy is unknown.


Bradyarrhythmias including AV block have been reported in the post-marketing setting. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. After one year administer 60 mg twice daily. Brilinfa recently had a heart attack, but I am not a victim. BRILINTA is used with aspirin to lower your chance of having another serious problem with your heart or blood vessels such as heart attack, stroke, or blood clots in your stent if you received one.

These can be fatal.

BRILINTA® (ticagrelor) tablets Plato Trial Bleeding Data

You may report side effects related to AstraZeneca products by clicking here. Plavix has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re infarction, or stroke.

Subject to eligibility rules ; restrictions apply. You may report side effects related to AstraZeneca products by clicking here. Call your doctor if you have new or unexpected shortness of breath or any side effect that bothers you or that does not go away.

Plavix has been shown to decrease the rate of a combined endpoint of cardiovascular death, myocardial infarction MIor stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia.


Bleeding will also take longer than usual to stop.

BRILINTA® (ticagrelor) tablets | Antiplatelet & Heart Attack Treatment

Your doctor can decide what treatment is needed. Strong inducers substantially reduce ticagrelor btilinta and so decrease the efficacy of ticagrelor As with other oral P2Y 12 inhibitors, co-administration of opioid agonists delay and reduce the absorption of ticagrelor.

Do not take new medicines that contain aspirin. Administer 90 mg twice daily during the first year after an ACS event.


People who are treated with a stent, and stop inserh BRILINTA too soon, have a higher risk of getting a blood clot in the stent, having a heart attack, or dying. For complete information on changes to the Plavix PI, go to www. The benefit for patients who undergo primary percutaneous coronary intervention is unknown.